Germany· DE-A57-2e1f6b05e9cbb08d
Metvix
A methyl aminolevulinate product containing methyl aminolevulinate, registered in Germany by Galderma Laboratorium Gmbh. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Methyl aminolevulinate is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XD03 (methyl aminolevulinate), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Methyl aminolevulinate · ATC L01XD03
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Methyl Aminolevulinate
- Manufacturer
- Galderma Laboratorium Gmbh
- Country
- Germany (DE)
- ATC code
- L01XD03
- ATC class
- Methyl aminolevulinate
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methyl aminolevulinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLuxeraGalderma Nordic AB
- SwedenLuxera 160 mg/g KrämGalderma Nordic AB
- United StatesKRX Aesthetics PD-13 TherapyBY KIN AESTHETICS LLC
- SpainMETVIX 160 mg/g CREMALaboratorios Galderma S.A.
- FranceMETVIXIA 168 mg/g, crèmeGALDERMA INTERNATIONAL
- BelgiumMetvix 160 mg/gGalderma Benelux
- IrelandMetvix 160 mg/g creamGalderma International
- IcelandMetvixGalderma Nordic AB*
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Luxerm, Metvix
- Belgium · Metvix
- Denmark · Metvix
- Spain · Metvix
- Finland · Metvix
- France · Metvixia
- United Kingdom (Northern Ireland) · Metvix
- Greece · Metvix
- Ireland · Metvix
- Iceland · Metvix
- Italy · Metvix
- Luxembourg · Metvix
- Malta · Metvix
- Netherlands · Metvix
- Norway · Metvix
- Portugal · Metvix
- Sweden · Luxera, Metvix
- Slovakia · Metvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c0c4197-3143-430c-b759-cbf52da224b3 GET /v1/drugs/8c0c4197-3143-430c-b759-cbf52da224b3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Methyl Aminolevulinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about methyl aminolevulinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.